SCHEMBL6133468

SCHEMBL6133468

CC(C)n1nc(-c2sc(NCc3ccccn3)nc2-c2ccccc2)ccc1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.41
ADORA1 P30542 3/20 0.41
MAPT P10636 4/20 0.40
KDM4E B2RXH2 4/20 0.40
NPSR1 Q6W5P4 2/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HIF1A Q16665 1/20 0.39
PTGS2 P35354 4/20 0.39
SUMO3 P55854 1/20 0.38
SUMO2 P61956 1/20 0.38
SUMO1 P63165 1/20 0.38
USP2 O75604 1/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6133314 0.91 HIF1A (0.41) ADORA2AADORA1MAPTMEN1KMT2A
SCHEMBL6133821 0.87 TGFBR1 (0.44) ADORA2AADORA1MAPTKDM4ENPSR1
Hydrochloric Acid SCHEMBL6828734 0.86 ADORA2A (0.47) ADORA2AADORA1MAPTKDM4ENPSR1
SCHEMBL6134249 0.85 TSHR (0.46) ADORA2AADORA1MAPTKDM4ENPSR1
SCHEMBL6133532 0.85 PTGS2 (0.44) ADORA2AADORA1MAPTALDH1A1PTGS2
SCHEMBL6133691 0.85 ADORA2A (0.46) ADORA2AADORA1MAPTKDM4ENPSR1
SCHEMBL6133757 0.83 ADORA1 (0.43) ADORA2AADORA1MAPTKDM4EMEN1
SCHEMBL6133360 0.83 PTGS2 (0.42) ADORA2AADORA1MAPTKDM4EALDH1A1
SCHEMBL6133910 0.82 MAPT (0.52) ADORA2AADORA1MAPTKDM4ENPSR1
SCHEMBL6133409 0.82 ADORA2A (0.57) ADORA2AADORA1MAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof MC2R, CYP2C9, OXTR ADORA2A 635/4885ADORA1 243/4885MAPT 3008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.